Research

Hormonal

Semaglutide (2.4 mg weekly) produces significantly greater weight loss than liraglutide (3.0 mg daily), orlistat, and phentermine in obese individuals.

If you have obesity or overweight with related health risks, Semaglutide (2.4 mg weekly) is currently the most effective pharmacological option for weight loss, significantly outperforming Liraglutide, Orlistat, and Phentermine. You must start at a low dose (0.25 mg) and increase it every 4 weeks to minimize stomach side effects. This medication works best when combined with diet and exercise changes.

StrongSupportsHIGH confidence
Results demonstrated that semaglutide resulted in significantly greater weight loss compared to liraglutide, with a mean weight reduction of 15.8% vs. 6.4%, respectively... The findings of the trial concluded that semaglutide 2.4 mg administered weekly is significantly more effective than liraglutide 3.0 mg administered daily for weight loss in adults without diabetes who are overweight or obese
Jay Prakash Patel et al. · Cureus · 2025

Why this rating

Based on multiple randomized controlled trials (Wilding, Marso, Rubino) and large retrospective cohorts with statistically significant p-values (<0.001).

Source

Comparative Effectiveness of Semaglutide, Liraglutide, Orlistat, and Phentermine for Weight Loss in Obese Individuals: A Systematic Review

Jay Prakash Patel et al. · Cureus · 2025

systematic_reviewCited 7×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →